Paper335960
Clinical and bacteriological evaluation of netilmicin in gram-negative infections.
Klastersky J and 4 others. Antimicrob Agents Chemother, 1977. Cited by 34 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Papers, record 335960. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/335960
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Gentamicins | Major topic |
| Sisomicin | Major topic |
| Bacteria | |
| Clinical Trials as Topic | |
| Drug Resistance, Microbial | |
| Humans |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 836,015 | In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/836015 | PubMed |
| 2 | 836,009 | Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/836009 | PubMed |
| 3 | 402,104 | In vitro activity of netilmicin, gentamicin, and amikacin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/402104 | PubMed |
| 4 | 401,853 | Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer. | J Infect Dis | 1977 | https://conductscience.org/library/papers/401853 | PubMed |
| 5 | 319,355 | Controlled comparison of amikacin and gentamicin. | N Engl J Med | 1977 | https://conductscience.org/library/papers/319355 | PubMed |
| 6 | 825,036 | In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/825036 | PubMed |
| 7 | 795,373 | In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/795373 | PubMed |
| 8 | 4,375,433 | Interaction of purulent material with antibiotics used to treat Pseudomonas infections. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4375433 | PubMed |
| 9 | 4,217,836 | Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods. | J Med Microbiol | 1974 | https://conductscience.org/library/papers/4217836 | PubMed |
| 10 | 4,596,743 | Clinical significance of in vitro synergism between antibiotics in gram-negative infections. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4596743 | PubMed |
| 11 | 4,599,859 | Comparative clinical study of tobramycin and gentamicin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4599859 | PubMed |
| 12 | 4,810,941 | Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4810941 | PubMed |
| 13 | 5,002,144 | Disc plate method of microbiological antibiotic assay. II. Novel procedure offering improved accuracy. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/5002144 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,425,615 | Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7425615 | PubMed |
| 6,992,711 | Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6992711 | PubMed |
| 2,689,137 | Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1989 | https://conductscience.org/library/papers/2689137 | PubMed |
| 761,144 | Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections. | Can Med Assoc J | 1979 | https://conductscience.org/library/papers/761144 | PubMed |
| 666,303 | Pharmacology and efficacy of netilmicin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/666303 | PubMed |
| 426,506 | Netilmicin in gram-negative bacterial infections. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/426506 | PubMed |
| 105,797 | Therapeutic experience with netilmicin. | Can Med Assoc J | 1978 | https://conductscience.org/library/papers/105797 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/335960
GET https://conductscience.org/api/papers/v1/335960/authors